Fundraising Fox

1910 Genetics

Cambridge, US · Founded 2018 · Delaware corporation · 6 known investors

1910genetics.com ↗

1910 Genetics develops genetic engineering and biotechnology solutions, leveraging computational and biological approaches. The company serves the biotech and life sciences industry.

AI & Machine LearningBiotechDeep Tech

Founders & leadership

1910 Genetics was founded in 2018 by Jennifer O. Nwankwo.

JOJennifer O. Nwankwo
Jennifer O. NwankwoFounderInvestor at Emles Venture Partners

Board

SK
Samir KumarBoard director
MF
Marc FosterBoard director
JBJory Bell
Jory Bellin𝕏Board directorGeneral Partner at Playground Global

Investors · 6

FoundersX Ventures✓ verifiedSilicon Valley
Playground Global✓ verifiedPalo Alto · $1M – $20M
Y Combinator✓ verifiedSan Francisco · $500K
Emles Venture PartnersNew York
M12 (Microsoft's Venture Fund)Seattle · $100K – $10M
Accenture VenturesreportedSan Francisco

Reported raises · per SEC filings

Form D private placements

$25.7M disclosed across 1 round · 2021

▶$25.7MraisedApr 2021 · 19 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Samir KumarDirector
  • Marc FosterDirector
  • Jennifer O. NwankwoExecutive Officer, Director
  • Jory BellDirector
Offering amount
$25.7M
Amount sold
$25.7M
First sale
Jan 2021
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Non-dilutive funding · 1 SBIR/STTR award

Federal grants — no equity taken
AgencyPhaseYearAmount
National Institutes of Health (NIH)National Institutes of HealthPhase ISTTR2021$546.4K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

In the news

Accenture Invests in 1910 Genetics to Enhance Drug Discovery With AIbiopharmatrend.com · Nov 20241910 Genetics Receives Investment from Accenture Venturesfinsmes.com · Oct 20241910 Genetics Start-Up Raises $22M to Use AI to Accelerate Drug Discovery – Unite.AIunite.ai · Mar 20211910 Genetics launches to accelerate therapeutics design - Drug Discovery World (DDW)ddw-online.com · Mar 20211910 Genetics Raises $26M in Seed and Series A Funding - FinSMEsfinsmes.com · Mar 20211910 Genetics Debuts with $26M to Accelerate the Design of Small Molecule and Protein Therapeutics Through AI, Computation and Biological Automationfinance.yahoo.com · Mar 2021

Frequently asked questions

What does 1910 Genetics do?
1910 Genetics develops genetic engineering and biotechnology solutions, leveraging computational and biological approaches. The company serves the biotech and life sciences industry.
Who founded 1910 Genetics?
1910 Genetics was founded by Jennifer O. Nwankwo in 2018.
Who are 1910 Genetics's investors?
1910 Genetics's investors include FoundersX Ventures, Playground Global, Y Combinator, Emles Venture Partners, M12 (Microsoft's Venture Fund), Accenture Ventures.
How much funding has 1910 Genetics raised?
1910 Genetics has disclosed $25.7M raised across 1 round.
Where is 1910 Genetics headquartered?
1910 Genetics is headquartered in Cambridge, US.